Chemokines and atopic dermatitis

This publication has 28 references indexed in Scilit:

• Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes
  The Journal of Experimental Medicine, 1997
• Lung immunopathology in cases of sudden asthma death
  European Respiratory Journal, 1997
• Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty–four hours after allergen challenge
  Journal of Allergy and Clinical Immunology, 1996
• Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis
  The Lancet, 1996
• Analysis of the Cytokine Pattern Expressed In Situ in Inhalant Allergen Patch Test Reactions of Atopic Dermatitis Patients
  Journal of Investigative Dermatology, 1995
• Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.
  The Journal of Experimental Medicine, 1994
• The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis
  Clinical and Experimental Allergy, 1993
• The role of eosinophils in the pathogenesis of atopic dermatitis ‐ eosinophil granule proteins as markers of disease activity
  Allergy, 1993
• RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.
  The Journal of Experimental Medicine, 1992
• Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic Dermatitis
  New England Journal of Medicine, 1985